喘息治療薬市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00021879
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 191
Buy Now

喘息薬市場は、2021 年の 242 億 3,917 万米ドルから 2028 年には 341 億 3,610 万米ドルに達すると予測されています。 2021 年から 2028 年にかけて、CAGR 5.0 % で成長すると推定されています。



喘息は、あらゆる年齢の人々に影響を与える肺疾患です。喘鳴が起こり、呼吸が困難になります。アレルギーや刺激物への曝露、感染症、運動、精神的ストレス、およびその他の状態はすべて潜在的な引き金です.喘息の症状が耐えられなくなると、喘息発作が起こります。攻撃はどこからともなく発生する可能性があり、軽度から生命を脅かすものまでさまざまです。喘息は、症状を治療するレスキュー吸入器と症状を予防するコントローラー吸入器で管理されます。重症例では、気道を開いたままにする長時間作用型吸入器 (ホルモテロール、サルメテロール、チオトロピウム) と吸入ステロイドが必要になる場合があります。喘息治療薬には、錠剤、注射、液体、吸入器など、いくつかの形態があり、気管支拡張薬と抗炎症薬などの 2 つのグループに分類されます。



喘息薬市場は投薬、投与経路、流通チャネル、および地理に基づいてセグメント化されています。地理に基づく市場は、北米、ヨーロッパ、アジア太平洋、中東およびアフリカ、南および中央アメリカに広く分割されています。喘息薬市場レポートは、市場規模、トレンド、ダイナミクスなどのパラメーターを強調して、市場の洞察と詳細な分析を提供します。市場における技術の進歩。ぜんそく薬市場における主要な市場プレーヤーの競争環境の分析。



戦略的洞察



そのようないくつかの要因大気汚染の環境への影響と遺伝への影響の増大、特定の民族グループの脆弱性の増加、粗い粒子状物質への曝露の増加、喘息を伴う生理学的障害の有病率の増加は、重大な短期、中期、長期の影響を与えると予想されるため今後数年間の喘息薬市場で。ただし、満たされていない医療ニーズと治療順守の欠如は、市場の成長を妨げています。市場レポートは、市場の成長に影響を与える可能性のある機会と将来の市場動向を特定します。



喘息薬市場の有利な地域



市場の洞察



大気汚染の環境への影響と遺伝的影響の増大

喘息は、変動する気流制限、気管支過敏性、および気道の炎症。 「喘息の結果に対する大気汚染の影響」というタイトルの総説論文によると、 Tiotiu らによると、大気汚染は大人と子供の喘息の転帰を妨げました。交通による大気汚染、二酸化窒素 (NO

2

)、および受動喫煙 (SHS) はすべて、子供の喘息発症の実質的な危険因子です。喘息の症状、増悪、および肺機能の低下は、外部汚染への曝露によって引き起こされる可能性があります。



米国では、大気汚染への曝露が引き続き喘息に関連しています。この深刻で生命を脅かす慢性呼吸器疾患は、2,300 万人を超えるアメリカ市民の生活の質に影響を与えています。大気汚染は喘息の症状を悪化させ、人々の間で喘息発作を引き起こす可能性があります。米国で最大 600 万人の子供に影響を与える喘息の子供は、汚染に対して特に脆弱です。



環境保護庁 (EPA) の資金提供を受けた新しい研究では、空気と空気の関係が分析されました。汚染と喘息。専門家は、大気汚染による主要な喘息の原因物質を特定することはできませんが、免疫系を制御する遺伝子を抑制して、アレルゲンとウイルスや細菌などの危険な異物を区別することを示唆する証拠があります。その後、免疫システムがオーバードライブ状態になり、薬が有毒であるかどうかに関係なく炎症反応を引き起こし、喘息を引き起こします。



スタンフォード大学の子供センターの研究者は、大気汚染の影響を調査しました。汚染レベルの高い地域の子供の免疫寛容に関与する2つの遺伝子。彼らは、多量の一酸化炭素 (CO)、NO

2

、および PM
への短期および長期暴露を発見しました。
2.5

(粒子状物質) は、喘息を引き起こすこれら 2 つの遺伝子の変化に関連していました。これらの調査結果は、大気汚染暴露のエピジェネティックな影響に焦点を当てており、喘息予防薬の開発に役立つ可能性があります。



これらの喘息研究のそれぞれが、子供の喘息の理解を改善し、人間の健康と環境を保護するために使用できる EPA への重要な情報。これらの研究活動を通じて、喘息の創薬と開発が促進され、喘息薬市場を牽引しています。



薬の種類に基づく洞察



薬に基づく世界の喘息薬市場は、即効薬と長期管理薬に分かれています。長期管理薬セグメントは、今後数年間で市場のより大きなシェアを保持すると予想されます。ただし、迅速な救済薬セグメントは、予測期間中により高い CAGR を記録すると予想されます。



薬による喘息薬市場 - 2021 年および 2028 年


< TIP>

投与経路に基づく洞察



投与経路に基づいて、喘息薬市場は吸入、プレフィルドシリンジ/バイアルなどに分割されます。吸入セグメントは2021年に市場で最大のシェアを占めており、予測期間中に大きなシェアを占めると予想されています。ただし、プレフィルド シリンジ/バイアル セグメントは、2021 年から 2028 年にかけて最高の CAGR を記録すると予想されます。



流通チャネルベースのインサイト



流通チャネルに基づいて、喘息薬市場はオンライン薬局、病院薬局、小売薬局に分割されます。小売薬局セグメントは、予測期間中に市場で最大のシェアを保持すると予想されます。ただし、オンライン薬局セグメントは、2021 年から 2028 年の間に最高の CAGR を登録すると予想されます。



喘息薬市場で事業を展開しているさまざまな企業は、製品の発売、合併、買収などの戦略を採用しています。コラボレーション、製品イノベーション、および製品ポートフォリオの拡張により、世界中にフットプリントを拡大し、ブランド名を維持し、増大する消費者の需要に応えます。市場に存在する主要なプレーヤーの一部はアストラゼネカです。テバ製薬工業株式会社;グラクソスミスクライン PLC;ベーリンガー インゲルハイム インターナショナル GmbH;メルク社; Koninklijke Philips NV;サノフィ;ファイザー社;ノバルティス AG;



Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the asthma drugs?

Asthma is a lung disease that affects people of all ages. It produces wheezing and makes breathing difficult. Exposure to an allergy or irritant, infections, exercise, emotional stress, and other conditions are all potential triggers. When the symptoms of asthma become unbearable, an asthma attack ensues. Attacks can happen out of nowhere and range in severity from mild to life-threatening. Asthma is managed with rescue inhalers to treat symptoms and controller inhalers that prevent symptoms. Severe cases may require longer-acting inhalers that keep the airways open (formoterol, salmeterol, tiotropium), as well as inhalant steroids. Asthma drugs come in several forms, including tablets, injections, liquids, and inhalers; and it falls into two groups: bronchodilators and anti-inflammatories.

What are the driving factors for the asthma drugs market across the globe?

The global asthma drugs market is being driven by factors such as growing environmental implications & genetic implications of air pollution, more vulnerability in specific ethnic groups, growing exposure to coarse particulate matters, and the growing prevalence of physiological disorders harboring asthma.

What are the restraining factors for the asthma drugs market across the globe?

The unmet medical needs and the lack of treatment adherence are the leading restraints that will hinder the asthma drugs market growth.

Who are the major players in the market the asthma drugs market?

The asthma drugs market comprises of players that include AstraZeneca, TEVA PHARMACEUTICAL INDUSTRIES LTD, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Merck & Co., Inc, Koninklijke Philips N.V., Sanofi, Pfizer Inc., Novartis AG, and Abbott are among others.

Which segment is dominating the asthma drugs market by medication?

The asthma drugs market on the basis of medication is bifurcated into quick relief medications and long-term control medications. In 2021, the long-term control medications segment accounted for a larger share in the global asthma drugs market.

Which segment is expected to dominate the asthma drugs market by route of administration?

On the basis of route of administration, the asthma drugs market is segmented into inhaled, prefilled syringe/vials, and others. The inhaled segment is expected to hold the largest share from 2021 to 2028. However, the prefilled syringe/vials segment is expected to grow at the highest CAGR during the forecast period.

The List of Companies - Asthma Drugs Market

  1. AstraZeneca
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD.
  3. GlaxoSmithKline plc
  4. Boehringer Ingelheim International GmbH
  5. Merck & Co., Inc.
  6. Koninklijke Philips NV
  7. Sanofi
  8. Pfizer Inc.
  9. Novartis AG
  10. Abbott

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports